Question 1

Who owns VRAX?

Accepted Answer

VIRAX BIOLABS GROUP LTD (VRAX) is held by 2 institutional investors that disclose positions via SEC 13F filings. The largest disclosed holder is OSAIC HOLDINGS, INC. as of Q1 2026.

Question 2

Are institutions buying or selling VRAX?

Accepted Answer

In Q1 2026, 0 institutions opened or increased positions in VIRAX BIOLABS GROUP LTD while 4 reduced or exited — a net selling quarter.

Question 3

What is the Smart Money Verdict on VRAX?

Accepted Answer

The Smart Money Verdict combines four independent sources (institutional 13F activity, insider trades, activist filings, and congressional trades) into a single assessment for VIRAX BIOLABS GROUP LTD.

Question 4

How many hedge funds hold VRAX?

Accepted Answer

2 institutional investors report holding VIRAX BIOLABS GROUP LTD (VRAX) as of Q1 2026, based on SEC 13F filings.

Question 5

Is institutional money flowing into VRAX?

Accepted Answer

As of Q1 2026, tracked institutions in VIRAX BIOLABS GROUP LTD show 0 buyers versus 4 sellers — net outflows.

Fund	Action	Shares	Value	Weight	Est. P&L
OSAIC HOLDINGS, INC.	Unchanged	20	$4	0.0%	+1065.71%
Farther Finance Advisors, LLC	Unchanged	21	$4	0.0%	+580.00%
NORTHWESTERN MUTUAL WEALTH MANAGEMENT CO	Exited	0(-100.0%)	$3	0.0%	-42.86%
XTX Topco Ltd	Exited	0(-100.0%)	$7,413	0.0%	-42.86%
UBS Group AG	Exited	0(-100.0%)	$2,592	0.0%	-56.72%
NATIONAL BANK OF CANADA /FI/	Exited	0(-100.0%)	$2,070	0.0%	-71.01%

VIRAX BIOLABS GROUP LTD

Continue exploring

Other Healthcare stocks held by institutions